BioLife Solutions Updates Earnings Call Information
BioLife Solutions (NASDAQ: BLFS), a leading developer and supplier of cell processing tools and services for the cell and gene therapy (CGT) market, has provided updated dial-in information for their earnings call scheduled for today at 4:30pm ET. U.S. participants can dial 1-833-630-0431, while international callers should use 1-412-317-1808.
BioLife Solutions specializes in providing solutions that maintain the health and function of biological materials throughout the collection, development, manufacturing, and distribution processes, supporting the commercialization of new therapies in the CGT market.
BioLife Solutions (NASDAQ: BLFS), un'azienda leader nello sviluppo e fornitura di strumenti e servizi per il trattamento cellulare nel mercato della terapia cellulare e genica (CGT), ha fornito informazioni aggiornate per la chiamata sugli utili prevista per oggi alle 16:30 ET. I partecipanti negli Stati Uniti possono chiamare il numero 1-833-630-0431, mentre i chiamanti internazionali devono utilizzare il numero 1-412-317-1808.
BioLife Solutions si specializza nel fornire soluzioni che mantengono la salute e la funzionalit脿 dei materiali biologici durante i processi di raccolta, sviluppo, produzione e distribuzione, supportando la commercializzazione di nuove terapie nel mercato CGT.
BioLife Solutions (NASDAQ: BLFS), un desarrollador y proveedor l铆der de herramientas y servicios para el procesamiento celular en el mercado de terapia celular y g茅nica (CGT), ha proporcionado informaci贸n actualizada para la llamada de resultados programada para hoy a las 4:30 pm ET. Los participantes en EE.UU. pueden marcar el 1-833-630-0431, mientras que los llamantes internacionales deben usar el 1-412-317-1808.
BioLife Solutions se especializa en ofrecer soluciones que mantienen la salud y funci贸n de los materiales biol贸gicos durante los procesos de recolecci贸n, desarrollo, fabricaci贸n y distribuci贸n, apoyando la comercializaci贸n de nuevas terapias en el mercado CGT.
BioLife Solutions (NASDAQ: BLFS)電� 靹疙彫 氚� 鞙犾爠鞛� 旃橂(CGT) 鞁滌灔鞚� 鞙勴暅 靹疙彫 觳橂Μ 霃勱惮 氚� 靹滊箘鞀るゼ 臧滊皽頃橁碃 瓿店笁頃橂姅 靹犽弰 旮办梾鞙茧, 鞓る姌 鞓ろ泟 4鞁� 30攵� ET鞐� 鞓堨爼霅� 鞁れ爜 氚滍憸 鞝勴檾 須岇潣鞚� 鞝戩啀 鞝曤炒毳� 鞐呺嵃鞚错姼頄堨姷雼堧嫟. 氙戈淡 雮� 彀戈皜鞛愲姅 1-833-630-0431搿� 鞝勴檾頃� 靾� 鞛堨溂氅�, 頃挫櫢 彀戈皜鞛愲姅 1-412-317-1808鞚� 鞚挫毄頃挫暭 頃╇媹雼�.
BioLife Solutions電� 靾橃, 臧滊皽, 鞝滌“ 氚� 鞙犿喌 瓿检爼 鞝勲皹鞐� 瓯胳硱 靸濍頃欖爜 氍检鞚� 瓯搓皶瓿� 旮半姤鞚� 鞙犾頃橂姅 靻旊（靺橃潉 鞝滉车頃橃棳 CGT 鞁滌灔 雮� 靸堧鞖� 旃橂氩曥潣 靸侅毄頇旊ゼ 歆�鞗愴晿電� 雿� 韸鬼檾霅橃柎 鞛堨姷雼堧嫟.
BioLife Solutions (NASDAQ : BLFS), un d茅veloppeur et fournisseur leader d'outils et services de traitement cellulaire pour le march茅 de la th茅rapie cellulaire et g茅nique (CGT), a fourni des informations mises 脿 jour pour sa conf茅rence t茅l茅phonique sur les r茅sultats pr茅vue aujourd'hui 脿 16h30 ET. Les participants am茅ricains peuvent composer le 1-833-630-0431, tandis que les appelants internationaux doivent utiliser le 1-412-317-1808.
BioLife Solutions se sp茅cialise dans la fourniture de solutions qui maintiennent la sant茅 et la fonctionnalit茅 des mat茅riaux biologiques tout au long des processus de collecte, d茅veloppement, fabrication et distribution, soutenant ainsi la commercialisation de nouvelles th茅rapies sur le march茅 CGT.
BioLife Solutions (NASDAQ: BLFS), ein f眉hrender Entwickler und Anbieter von Zellverarbeitungstools und -dienstleistungen f眉r den Zell- und Gentherapiemarkt (CGT), hat aktualisierte Einwahlinformationen f眉r seine Gewinnbekanntgabe, die heute um 16:30 Uhr ET stattfindet, bereitgestellt. US-Teilnehmer k枚nnen die Nummer 1-833-630-0431 w盲hlen, internationale Anrufer sollten 1-412-317-1808 verwenden.
BioLife Solutions ist darauf spezialisiert, L枚sungen bereitzustellen, die die Gesundheit und Funktion biologischer Materialien w盲hrend der Sammlung, Entwicklung, Herstellung und Verteilung erhalten und so die Kommerzialisierung neuer Therapien im CGT-Markt unterst眉tzen.
- None.
- None.
About BioLife Solutions
BioLife is a leading developer and supplier of cell processing tools and services for the CGT market. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during the collection, development, manufacturing and distribution. For more information, please visit , and follow BioLife on and .
Media & Investor Relations
At the Company
Troy Wichterman
Chief Financial Officer
(425) 402-1400
[email protected]听
Investors
Alliance Advisors IR
Jody Cain
(310) 691-7100
[email protected]
View original content to download multimedia:
SOURCE BioLife Solutions, Inc.
FAQ
When is BioLife Solutions (BLFS) Q1 2025 earnings call?
What are the dial-in numbers for BioLife Solutions' earnings call?
What does BioLife Solutions (BLFS) do?
Who is the CFO of BioLife Solutions (BLFS)?
